GANX logo

Gain Therapeutics (GANX) Shareholders Equity

Annual Shareholders Equity

$12.58 M
-$6.30 M-33.38%

December 31, 2023


Summary


Performance

GANX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGANXbalance sheetmetrics:

Quarterly Shareholders Equity

$8.91 M
-$2.88 M-24.40%

September 30, 2024


Summary


Performance

GANX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGANXbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

GANX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.4%0.0%
3 y3 years+102.8%0.0%
5 y5 years-0.0%

GANX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-63.9%at low-74.4%+21.5%
5 y5-year-63.9%+2895.8%-80.0%+43.6%
alltimeall time-63.9%+2895.8%-80.0%+43.6%

Gain Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$8.91 M(-24.4%)
Jun 2024
-
$11.78 M(+36.4%)
Mar 2024
-
$8.64 M(-31.3%)
Dec 2023
$12.58 M(-33.4%)
$12.58 M(+71.6%)
Sep 2023
-
$7.33 M(-33.9%)
Jun 2023
-
$11.09 M(-26.7%)
Mar 2023
-
$15.14 M(-19.8%)
Dec 2022
$18.88 M
$18.88 M(-16.7%)
Sep 2022
-
$22.66 M(-16.1%)
DateAnnualQuarterly
Jun 2022
-
$27.02 M(-15.1%)
Mar 2022
-
$31.83 M(-8.6%)
Dec 2021
$34.82 M(+461.4%)
-
Dec 2021
-
$34.82 M(-7.3%)
Sep 2021
-
$37.55 M(-9.3%)
Jun 2021
-
$41.39 M(-6.9%)
Mar 2021
-
$44.46 M(+616.9%)
Dec 2020
$6.20 M(-1478.5%)
-
Dec 2020
-
$6.20 M
Dec 2019
-$449.90 K
-

FAQ

  • What is Gain Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Gain Therapeutics?
  • What is Gain Therapeutics annual shareholders equity year-on-year change?
  • What is Gain Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Gain Therapeutics?
  • What is Gain Therapeutics quarterly shareholders equity year-on-year change?

What is Gain Therapeutics annual stockholders equity?

The current annual shareholders equity of GANX is $12.58 M

What is the all time high annual shareholders equity for Gain Therapeutics?

Gain Therapeutics all-time high annual stockholders equity is $34.82 M

What is Gain Therapeutics annual shareholders equity year-on-year change?

Over the past year, GANX annual stockholders equity has changed by -$6.30 M (-33.38%)

What is Gain Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of GANX is $8.91 M

What is the all time high quarterly shareholders equity for Gain Therapeutics?

Gain Therapeutics all-time high quarterly stockholders equity is $44.46 M

What is Gain Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, GANX quarterly stockholders equity has changed by $0.00 (0.00%)